195 related articles for article (PubMed ID: 37605227)
1. Combination of adipose-derived stem cell conditioned media and minoxidil for hair regrowth in male androgenetic alopecia: a randomized, double-blind clinical trial.
Legiawati L; Suseno LS; Sitohang IBS; Yusharyahya SN; Pawitan JA; Liem IK; Kurniawati T; Ardelia A; Paramastri K
Stem Cell Res Ther; 2023 Aug; 14(1):210. PubMed ID: 37605227
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Minoxidil Combined With Photobiomodulation for the Treatment of Male Androgenetic Alopecia. A Double-Blind Half-Head Controlled Trial.
Ferrara F; Kakizaki P; de Brito FF; Contin LA; Machado CJ; Donati A
Lasers Surg Med; 2021 Nov; 53(9):1201-1207. PubMed ID: 33998004
[TBL] [Abstract][Full Text] [Related]
3. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.
Penha MA; Miot HA; Kasprzak M; Müller Ramos P
JAMA Dermatol; 2024 Jun; 160(6):600-605. PubMed ID: 38598226
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
[TBL] [Abstract][Full Text] [Related]
5. Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study.
Bassiouny EA; El-Samanoudy SI; Abbassi MM; Nada HR; Farid SF
Arch Dermatol Res; 2023 Jul; 315(5):1293-1304. PubMed ID: 36571611
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Conditioned Media From Human Adipocyte-Derived Mesenchymal Stem Cells on Androgenetic Alopecia After Nonablative Fractional Laser Treatment.
Lee YI; Kim J; Kim J; Park S; Lee JH
Dermatol Surg; 2020 Dec; 46(12):1698-1704. PubMed ID: 32769526
[TBL] [Abstract][Full Text] [Related]
7. Curcuma aeruginosa, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study.
Pumthong G; Asawanonda P; Varothai S; Jariyasethavong V; Triwongwaranat D; Suthipinittharm P; Ingkaninan K; Leelapornpisit P; Waranuch N
J Dermatolog Treat; 2012 Oct; 23(5):385-92. PubMed ID: 21756154
[TBL] [Abstract][Full Text] [Related]
8. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo-controlled trial.
Uzel BPC; Takano GHS; Chartuni JCN; Cesetti MV; Gavioli CFB; Lemes AM; Costa IMC
Dermatol Ther; 2021 Jan; 34(1):e14622. PubMed ID: 33269529
[TBL] [Abstract][Full Text] [Related]
9. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
Suchonwanit P; Rojhirunsakool S; Khunkhet S
Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
[TBL] [Abstract][Full Text] [Related]
10. A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men.
Hillmann K; Garcia Bartels N; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
Skin Pharmacol Physiol; 2015; 28(5):236-44. PubMed ID: 25765348
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
[TBL] [Abstract][Full Text] [Related]
12. Topical minoxidil therapy in hereditary androgenetic alopecia.
De Villez RL
Arch Dermatol; 1985 Feb; 121(2):197-202. PubMed ID: 3883902
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
[TBL] [Abstract][Full Text] [Related]
14. Autologous Concentrated Growth Factors Combined with Topical Minoxidil for the Treatment of Male Androgenetic Alopecia: A Randomized Controlled Clinical Trial.
Tan PC; Zhang PQ; Xie Y; Gao YM; Li QF; Zhou SB; Liu Q; Liu K
Facial Plast Surg Aesthet Med; 2021; 23(4):255-262. PubMed ID: 32833539
[No Abstract] [Full Text] [Related]
15. A randomized, double-blind, vehicle-controlled clinical study of hair regeneration using adipose-derived stem cell constituent extract in androgenetic alopecia.
Tak YJ; Lee SY; Cho AR; Kim YS
Stem Cells Transl Med; 2020 Aug; 9(8):839-849. PubMed ID: 32420695
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study.
Hossein Mostafa D; Samadi A; Niknam S; Nasrollahi SA; Guishard A; Firooz A
J Pharm Pharm Sci; 2021; 24():191-199. PubMed ID: 33909554
[TBL] [Abstract][Full Text] [Related]
17. Sequential Scalp Assessment in Hair Regeneration Therapy Using an Adipose-Derived Stem Cell-Conditioned Medium.
Narita K; Fukuoka H; Sekiyama T; Suga H; Harii K
Dermatol Surg; 2020 Jun; 46(6):819-825. PubMed ID: 31490301
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male Androgenetic alopecia.
Bao L; Gong L; Guo M; Liu T; Shi A; Zong H; Xu X; Chen H; Gao X; Li Y
J Cosmet Laser Ther; 2020; 22(1):1-7. PubMed ID: 29028377
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation.
Ghonemy S; Alarawi A; Bessar H
J Dermatolog Treat; 2021 Mar; 32(2):236-241. PubMed ID: 31403367
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of electrodynamic microneedling combined with 5% minoxidil topical solution for treating androgenetic alopecia in Chinese males and molecular mechanistic study of the involvement of the Wnt/β-catenin signaling pathway.
Bao L; Zong H; Fang S; Zheng L; Li Y
J Dermatolog Treat; 2022 Feb; 33(1):483-493. PubMed ID: 32412314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
